Conference tag line

Jeff Duchemin is the vice president of sales for BD Biosciences and Discovery Labware. In his current role, Jeff is responsible for developing, implementing and retaining strategic sales objectives in line with business unit profit and financial goals. Becton Dickinson (BD) is a GLOBAL medical technology company that develops, manufactures and sells medical supplies, devices, laboratory equipment, and diagnostic equipment worldwide. Its market cap is 16 billion with 7.2 in revenue.

During his 12-year tenure with the firm, Jeff has help progressive sales management and leadership responsibilities across BD's three business segments: BD Diagnostics, BD Medical and BD Biosciences.

Prior to his current position, Jeff served in such roles as: strategic account manager, regional business manager, director US sales, and director sales - americas. The depth of his experience spans across a diverse range of medical device markets including: Diagnostics, Diabetes, Medical Surgical, Ophthalmic, and Life Science.

Mr. Duchemin received his BS in Accounting from the University Of Massachusetts, Dartmouth and an MBA from Southern New Hampshire University.

Dr. Barnhill is a Physician trained in Laboratory Medicine/Clinical Pathology and a Pioneer in the development of Artificial Intelligence and Pattern Recognition Computational Techniques used in Medicine, Genomics, Proteomics, Diagnostics and Drug Discovery.

Dr. Barnhill was the founder and CEO of the Barnhill Clinical Laboratories, which was acquired by Quest Diagnostics.

Dr. Barnhill is a co-inventor of the first neural network patents used in medicine, which were acquired by Johnson & Johnson. He is also the inventor of the first support vector machine patents used in medicine for genomic discovery. In addition, Dr. Barnhill is the sole inventor or co-inventor on numerous issued pioneer patents in artificial intelligence based machine learning techniques and diagnostic discovery; was instrumental in the development of neural network based diagnostic tests for prostate and ovarian cancer, led the team that identified and patented the genes that cause colon cancer; has numerous peer-reviewed publications in medical and scientific journals and has been a featured speaker at major medical conferences, both Internationally and in the United States.

Massimo Carrara has served as the vice president, global strategic marketing, for Bracco Diagnostics Inc. (BDI), since 2007. Carrara has the dual role of leading Bracco’s global strategic marketing organization as well as the vice president of BDI marketing. Through his position, he drives the mission of the global marketing communications and initiatives of BDI including global market share growth and maximizing the demand for its contrast media product portfolio while delivering customer-driven solutions.

Carrara spent 10 years, from 1995 to 2010, in increasing levels of responsibility within the sales and marketing arena of Bracco, where his positions included worldwide sales and marketing development manager of Bracco Imaging in Milan, Italy, and general manager of Bracco Diagnostics Canada. Carrara leverages his extensive experience of understanding the marketing operations of the diagnostic imaging industry, both domestically and internationally.

Prior to his tenure with Bracco, Carrara spent five years with Nycomed Amersham (now GE Healthcare) in Italy, where his positions included nuclear oncology business manager and contrast media marketing manager.

Carrara earned his master’s degree from Columbia Business School in New York with a double major in finance and organization.

Dennis Upah joined HealthCentral in October of 2002 as Executive Vice President, Broadcast, putting his over 20 years of media and Internet health experience to work in developing multi-media patient marketing strategies for the company and its global medical device clients. Previously, Upah was the President and CEO of VisionWeb, the leading global eMarketplace consortium for the vision care industry. From 1999-2000, he was the Chief Operating Officer of drkoop.com, overseeing the portal’s day-to-day operations and building content relationships with online companies, hospitals and television stations coast-to-coast. Prior to his work in the Internet, Upah had 17 years of success in running television stations and developing Web strategies for Granite Broadcasting, the largest publicly-traded minority owned broadcasting corporation in America. At KEYE-TV in Austin, Texas, Dennis orchestrated what CBS-TV called its “best affiliation switch performance” in the U.S., increasing the value of the property by $100M in just four years as its sole President. At WEEK-TV in Peoria, Illinois, he became the youngest affiliate President & GM in the history of NBC-TV, leading that station to ratings and revenue dominance for seven years. Upah was the valedictorian of his graduating class at Bradley University, and was named one of the Internet’s Top 25 Marketing Executives by Advertising Age magazine in 1999.

An award winning sales and marketing executive with progressive business and sales experience in the Pharmaceutical and Medical Device arena. Builds highly effective teams through successful recruiting, training, coaching and motivating sales and marketing professionals.

Covidien Imaging Solutions

Present Director of Marketing Contrast Media and Delivery systems: Marketing director for a $300M imaging franchise, which includes Imaging and Cardiac Cath Lab pharmaceuticals and device products. BD&L activities in this area include line extensions, acquisitions (with integration) and licensing agreements.

Full P&L responsibilities. Responsible for traditional marketing of both devices and pharmaceutical s as well key decision maker in strategic BD&L activities. Responsibilities also include sales force direction, targeting, sales training, professional development of staff, business planning, forecasting, A&P budgeting, medical conference identification and planning, global messaging and support.
Significant accomplishments include:

• Re-Branded Imaging Pharmaceutical 2009
• Pharma/device combo launch 2008
• Prefilled Saline product launch 2007
• Oral Contrast launch post recall 2006
• Device Injector launch 2005
• Re-branded Pharma and Device (2006/2008)

Director of Sales Urology Systems

Present Responsible for $20M sales P&L with 15 direct reports/managers/clinical support personnel. $250K capital equipment purchase. Responsibilities include recruiting, retaining, training and developing Urology Sales Representatives for optimum performance in a constrained capital marketplace.

• President's club reps 2010
• Accessories launch 2010

Sr. Marketing Manager

Responsible for identifying strategic acquisition, co-promote, co-development and license opportunities from both US and Ex-US partners to expand existing field sales force. Complete business cases completed for each opportunity identified, screened and presented to executive leadership. Therapeutic areas have focused on pain, orthopedics and oncology, CNS and primary care. Develop all strategy and positioning for all brand opportunities. Also responsible for clinical development of all programs related to the Brand promoted products (including Phase IV, II and III). Designed and implemented two phase IV studies that resulted in two publications in 2004. Successfully managed the internal product pipeline through the PDP process, resulting in FDA submissions for three products. Responsibilities also include recruiting, training and developing managers reporting directly to me.

• 2002 Circle of Excellence award winner
• 2004 Circle of Excellence award winner

Tyco Healthcare - Mallinckrodt Pharmaceuticals

Product Manager: CNS and Pain products

Responsible for traditional product management of Methylin, Tofranil PM and Restoril.

• 2002 Presidents Cup

Johnson & Johnson - ORTHO BIOTECH

Product Manager (Interim): SPORANOX IV & OS

Product Manager for a $25 MM critical care pharmaceutical. Target audience included intensive care and infectious disease specialists. Successfully launched a new product indication into the US critical care market.

Critical Care Surgery District Manager

District Sales Manager for eleven Hospital Product Specialists in a $7.2MM district. Responsibilities include recruiting, retaining, training and developing Hospital Representatives for optimum performance. Significantly drove sales of PROCRIT and SPORANOX IV/OS from 1997-2001, resulting in significant corporate recognition, including receipt of the following awards for goal/quota achievement and participation in the following special projects and committees:

• 2000 Teal Diamond Award
• 1999 District Manager of the Year Award
• 1999 Johnson & Johnson Leadership Award
• 1998 Teal Diamond Award
• 1997 Teal Diamond Award
• 1999 - 2001 Marketing Advisory Board Member
• Managed a $2M Speakers Bureau (promotional and CME) and implemented field rollout
• Designed and implemented national field training program focusing on product knowledge, business planning and implementation
• Trained and mentored new District Managers
• Developed and implemented management training programs focusing on performance management and staff development and interviewing practices
• Selected to participate in a J&J Corporate Credo Evaluation
• Selected to participate in two J&J Corporate Feedback Sessions
• 1997 - 1999 National Biofeedback Representative

Surgical Product Specialist

Responsible for changing standard of care in targeted orthopedic/spine surgical markets.

• 1996 Teal Diamond Award Winner.

John Norris is a Former Principal Deputy Commissioner and COO of the US FDA in Washington, DC, where he is best known for having led the last highly successful FDA-reform initiative in the Agency's storied history, from May 1984 to May 1988. This work was performed under the overall leadership and guidance of President Ronald Reagan, HHS Secretaries Margaret Heckler and Dr. Otis Bowen, FDA Commissioner Dr. Frank Young, Senator Orrin Hatch, and Congressman Paul Rogers.

He is currently COO of Health Discovery Corporation, a healthcare-IT company having 70 patents and patents pending in the pattern-recognition and personalized-medicine fields, and Chairman of Norris Capital.

Until recently, he simultaneously also taught healthcare policy and management (including healthcare-reform, Medicare-reform, healthcare-IT-reform, personalized-medicine-reform, and FDA-reform) at Harvard University, and was Founder and Faculty-Editor-in-Chief of the American Journal of Law, Medicine, and Ethics, a leading academic publication covering healthcare policy, law, regulation, management, finance, and ethics.

He has been the CEO to a significant number of successful life-sciences and healthcare-IT companies and has served on the boards of and/or consulted with dozens more. For example, he helped champion the billion dollar turn-around of the laser eye surgery company, Summit Technology, and he was Chairman of the Board of the American Society of Law, Medicine, and Ethics. Additionally, he has consulted with senior executives of leading companies, including Pfizer, Merck, J&J, and Glaxo, among others.

Through extensive public speaking, writing, editing, and publishing, he helped to popularize four common phrases: "actionable-insights-generation," "medical-knowledge-processing," "minimally-invasive-care,"" and "pressure-point-regulating."

His overall goal for America is the wide-scale deployment of highly-tuned personalized medicine, where optimally-benchmarked, low-cost, high-impact, relatively-safe, and "absolutely-right" products and services, of the right quality and quantity, are given to the right patient, at the right time, at the right place, and in the right dose, the first time, and every time.

Dr. Sanders founded ECI in 1998. Dr. Sanders is a leader in the field of protein engineering, purification and diagnostic assay development. Dr. Sanders worked as a Senior Scientist II at Genome Therapeutics in the Pathogen Genetics Program. He holds a Ph.D. in Biomedical Sciences from WPI, and completed postdoctoral training at the Whitehead Institute at MIT. Dr. Sanders has dual assistant research professor appointments in the Bioengineering Institute and the Biology and Biotechnology Department at WPI. He serves on numerous scientific and entrepreneurial boards at local universities and is chair of Salem Covenant Church. For ECI, Dr. Sanders secured an aggregate $18M in equity, corporate development funding, and SBIR grants.

Patrick F. Terry: A venture philanthropist, social entrepreneur, and a leader in the emerging field of personalized medicine who has founded a series of philanthropic, research, and commercial organizations based on the life sciences, applied technology, and social-network theory. He is co-founder of Genomic Health [NASDAQ:GHDX], and a former Director at this pioneering personalized medicine company. His perspective is forged from personal and family experiences with genetic disease, cancer, and extensive work in the patient advocacy community. He has published dozens of peer-reviewed scientific papers, articles, and book chapters in the fields of genetics, translational research, and personalized medicine. Some of his recent activities included leadership positions on numerous trade associations, professional societies, corporate boards, and federal advisory bodies. He has experience doing hands-on bench science, coordinating genetics research, advancing discoveries for rare diseases, and managing multiple life science patents. He has received many honors and awards in the business and scientific communities in the U.S. and internationally. He has dedicated his career to helping people and advancing a patient-centered perspective in research and product development,. He is currently a Director at Sirius Genomics, TcLand Expression, BioLogos Foundation, RedOak Logic, and GRAND Therapeutics.

Patrick has founded the following organizations: Personalized Medicine Coalition, 21st Century Medicine Coalition, PXE International, Genetic Alliance BioBank, International Genetic Alliance, European Personalized Medicine Diagnostic Association, BioLogos Foundation, DiRx Diagnostics, and GRAND Therapeutics.

Mr. Christensen brings over 30 years of experience in global, national and regional sales leadership for small and large multi-national medical device companies. In addition, Mr. Christensen has been involved in creating, expanding and reorganizing multi-national field sales network operations including direct and indirect sales staff.

Prior to joining NeuroMetrix, Mr. Christensen was the Senior Vice President of Global Sales at Stereotaxis, Inc. At Stereotaxis he created sales and business network strategies that established market share in Asia, Europe and the United States. Prior to Stereotaxis Mr. Christensen was Vice President, mid America zone at Philips Medical Systems. At Philips Medical Systems he created and expanded a successful U.S. sales operation that integrated the use of field sales personnel and a large dealer organization. Previously, Mr. Christensen served as General Manager at General Electric Medical Systems where he was responsible for the Nuclear/PET Division in North and South America. Mr. Christensen received his degree in business administration from Harrisburg Community College, Harrisburg, PA and his Radiology Technology Certification from Holy Spirit Hospital, Camp Hill, PA.

He has an MBA from the University of Chicago and a B-Phil from the University of Pittsburgh.

Marshall Solem is responsible for ZS Associates Midwest Region, consisting of more than 225 consulting professionals. His client work is primarily focused on the medical products and services sector of the health care market. Marshall has worked on new product launch effectiveness, market segmentation, go-to-market strategy, sales and marketing organization design, territory alignment, incentive compensation and sales force effectiveness. He holds a Bachelor of Business Administration in management and finance from the University of Wisconsin-Madison and Master of Management degree from Northwestern University's Kellogg Graduate School of Management.

Steve Gielda is an independent performance consultant who has spent over 20 years working with sales and sales management teams in Fortune 500 companies to improve sales performance. Throughout the past 10 years he has invested the majority of his time working in the medical device market. Both his internal and external clients have recognized Steve for his emphasis on, and willingness to forge strong relationships built on client intimacy and willingness to help drive business results.

Throughout the mid to late 90's Steve worked closely with Neil Rackham (author of SPIN Selling and Rethinking the Sales Force) to create unique solutions for his clients. Prior to working with Neil Rackham, he was Vice President of Sales and Channel Management at CTN, an office equipment manufacturing and distribution company. Prior to CTN, he worked with Lanier Worldwide for 10 years in a variety of increasingly responsible positions, including Sales Manager and District Manager. He was later promoted to Regional Manager of Lanier Professional Services.

Today he is a senior partner and principal with Sales Momentum, a sales simulation and consulting organization dedicated to partnering with customers to implement highly customized performance change projects for building world-class sales teams. He is a sought after guest speaker and author of many articles focused on sales effectiveness, effective coaching, and product launches.

Steve currently works with many leading medical device manufacturers and distributors to improve sales process and performance. A few of his active clients are; Medtronic, Owens & Minor, CR Bard, Covidien, Quest Diagnostics, Beckman Coulter, Bayer Diagnostics, STERIS Corporation, MEDRAD, Spacelabs, Boston Scientific, and Kimberly Clark.

At TIBCO Spotfire, Bill is responsible for leading the company's "go to market" campaign to the Managed Markets, Field Support, Sales Operations and Marketing sides of Life Sciences. In that role he has worked with dozens of pharmaceutical companies and 8 MDD companies. They range from divisions of integrated, worldwide life sciences corporations to small organizations with a few products. Bill helps direct Spotfire product development, marketing, and messaging for that marketplace.

Prior to that role, he spent 3 years at IMS Health in a similar capacity, and prior to that was the MidAtlantic lead for Arthur Andersen's life sciences sales & marketing support practice for three years. He also worked for an interactive agency that created some of the first product web sites for life sciences accounts in the PA-NJ region. He has thirty years experience with various nationally-known consulting and technology firms.

Bill holds BA from Franklin & Marshall College, an MBA from Eastern University, and a PhD from St Andrews University (Scotland). He has taught courses in Information Technology at Wilmington College in Delaware, where he lives.

Pete Masloski is a Principal at ZS Associates in Evanston, Ill., and is the leader of ZS's Medical Products and Services practice. His areas of expertise include opportunity assessment, segmentation, sales process and channel design, sales force strategy, competency assessment, territory alignment, incentive compensation, and account management. Pete holds a BSE in chemical engineering from Princeton University and an M.B.A with honors from Northwestern University's Kellogg Graduate School of Management.

Bret Caldwell is a Principal at ZS Associates in Evanston, Ill., focusing on the medical products and services sector. His experience is in sales force sizing and structure, sales force reporting and automation, territory alignment, segmentation and targeting, productivity, and compensation. Bret holds an MBA from the Wharton School of the University of Pennsylvania, with a concentration in Marketing and Operations. He also has a Masters in International Studies from the University of Pennsylvania and a BA in Economics from Stanford University.

As Vice President of Life Sciences for Prolifiq, Maureen Shaffer is responsible for strategic leadership and definition of products, services, and strategy for the pharmaceutical, medical device, and biotech space. She is focused on providing cloud-based software and solutions that systematically and comprehensively embed Good Promotional Practices into sales and marketing practices, allowing companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences is used to organize, send and track approved sales materials via leading mobile platforms to health care practitioners.

Maureen brings more than 20 years of experience developing and launching pioneering technologies in industry-leading medical device companies. Most recently, she was Vice President of Marketing at InSet Technologies, Inc., a developer of implantable pumps for targeted intraspinal drug delivery to treat chronic pain. Prior to that, Maureen was Vice President of Marketing at AtriCure, Inc., a NASDAQ-listed pioneer in minimally invasive cardiac ablation. Maureen's extensive career includes launching the first angioplasty balloon with Cordis Corporation; introducing a market-changing product to replace vascular sutures at United States Surgical; and bringing to market more than 100 minimally invasive cardiac surgery devices at Heartport, Inc. She holds a B.S. in Biomedical Engineering from Duke University.

As President and Founder of SEEK Medical Consulting, LLC, Sean McCarthy specializes in helping to expand sales distribution channels for medical device and life sciences companies. This allows companies to introduce new products to market into an already established channel or enable existing products to expand their footprint in the marketplace. In addition, SEEK Medical Consulting, LLC, consults with hospital administrators and physicians to expand their patient volume through a turnkey referral development program that drives revenue to the institution and practice.

AtriCure, he helped to establish the US Central Area sales force as Director of Sales, then developed a national referral development initiative for the company’s ablation devices in the newly formed Director of Strategic Marketing role, and finally held the Director of the Strategic Business Unit position where he was responsible for the sales and marketing of the minimally invasive surgery (MIS) platform nationally. Prior to this, in 2000 when surgical robotics was little more than a curiosity, Sean joined Intuitive Surgical (ISRG). Over his career at ISRG, Sean grew from one of the initial sales trainees on to Sales Director for the Midwest region to oversee all field sales activities and establish the da Vinci® system and the field sales team in the Central US. Sean’s career in medical device sales began at Johnson & Johnson’s Ethicon Endo-Surgery. He holds a BA in education from Colgate University in Hamilton, NY.

Kiran Mysore leads the Business Intelligence (BI) program at St. Jude Medical, US Division (USD). At USD, Kiran’s efforts center around empowering a highly productive, top performing, and well-informed sales and marketing organization through an effective implementation of BI. Kiran has over 14 years of in-depth experience in BI, and has led efforts at several Fortune-500 companies to realize the alue and impact of BI. Kiran has a Master of Science degree from Vanderbilt University and resides in Minneapolis, MN.